Optimized Intensity Modulated Irradiation for Head and Neck Cancer

NCT00580983 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

RADIATION: IMRT
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: 5-Fluorouracil

Sponsor

University of Michigan Rogel Cancer Center